Cholangiocarcinoma

Showing 1 - 25 of 240

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)

Not yet recruiting
  • Cervical Cancer
  • +13 more
  • (no location specified)
Sep 28, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

Not yet recruiting
  • Cholangiocarcinoma
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Colorectal Cancer, Pancreatic Cancer, Gastric Cancers Trial in Canada, Korea, Republic of, United States (BOLD-100 in

Recruiting
  • Colorectal Cancer
  • +3 more
  • BOLD-100 in combination with FOLFOX Chemotherapy
  • Santa Monica, California
  • +12 more
Aug 18, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Metastatic Colorectal Cancer (Mcrc), Intrahepatic Cholangiocarcinoma (Icc), Colorectal Cancer Trial run by the National Cancer

Not yet recruiting
  • Metastatic Colorectal Cancer (Mcrc)
  • +7 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

Not yet recruiting
  • Biliary Tract Cancer
  • +3 more
  • (no location specified)
Aug 16, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Aug 15, 2022

The PLATON Network

Recruiting
  • Hepatocellular Cancer
  • +5 more
    • Frankfurt, Hessen, Germany
    • +30 more
    Aug 12, 2022

    Hepatocellular Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Germany (FoundationOne®CDx and FoundationOne®Liquid)

    Recruiting
    • Hepatocellular Cancer
    • +5 more
    • FoundationOne®CDx and FoundationOne®Liquid
    • Frankfurt, Hessen, Germany
    • +29 more
    Aug 12, 2022

    Hepatobiliary Cancer, Pancreatic Cancer, Hepatocellular Carcinoma Trial in Orange (ctDNA Blood Collection)

    Not yet recruiting
    • Hepatobiliary Cancer
    • +5 more
    • ctDNA Blood Collection
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 9, 2022

    Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

    Recruiting
    • Cholangiocarcinoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2022

    Breast Cancer, Cholangiocarcinoma, Ovarian Cancer Trial in Worldwide (AZD8205)

    Recruiting
    • Breast Cancer
    • +3 more
    • Duarte, California
    • +11 more
    Aug 5, 2022

    Hepatocarcinoma, Cholangiocarcinoma, Quality of Life Trial in Rozzano (Synchrolevels)

    Completed
    • Hepatocarcinoma
    • +2 more
    • Synchrolevels
    • Rozzano, Lombardia, Italy
      Humanitas Research Hospital
    Aug 2, 2022

    Cholangiocarcinoma Trial in Birmingham (Novel combination of chemo and immunotherapy)

    Recruiting
    • Cholangiocarcinoma
    • Novel combination of chemotherapy and immunotherapy
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 28, 2022

    Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

    Recruiting
    • Gynecologic Cancer
    • +11 more
    • Neoantigen specific TCR-T cell drug product
    • Aldesleukin (IL-2)
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    HLA Typing and Tumor Neoantigen Identification forPhase I/II

    Recruiting
    • Ovarian Cancer
    • +5 more
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      Subjects Treated With Autologous T Cells Using Sleeping Beauty

      Not yet recruiting
      • Gynecologic Cancer
      • +9 more
      • Neoantigen specific TCR-T cell drug product
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

      Terminated
      • Neoplasms
      • +27 more
      • Culver City, California
      • +28 more
      Jul 25, 2022

      Uterine Cervical Tumors, Endometrial Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Worldwide

      Recruiting
      • Uterine Cervical Neoplasms
      • +10 more
      • Pembrolizumab/Vibostolimab Co-Formulation
      • +11 more
      • Anchorage, Alaska
      • +63 more
      Jul 22, 2022